Rising Incidence of Surgical Site Infections (SSIs) Fuels Preoperative Infection Prevention & Wound Cleansing Device Market

According to our new research study on "Preoperative Infection Prevention & Wound Cleansing Device Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Product, Surgery, and Application," the market was valued at US$ 1,994.76 million in 2021 and is projected to reach US$ 3,112.36 million by 2028; it is expected to grow at a CAGR of 6.6% from 2022 to 2028. The report highlights trends prevailing in the market and drivers and restraints pertaining to the market growth.

Surgical Site Infection (SSI) is the most common nosocomial infection and a common side effect of gastrointestinal surgery. Gastrointestinal surgical procedures and wound closure methods influence the occurrence of superficial wound infections. There has been a faster increase in simple incisional SSI infection cases than in deep incisional SSI and organ or space SSI. SSIs are treated with antibiotics; however, sometimes, additional procedures are needed to treat the infection. The rising geriatric population with compromised immunity and the increasing surgical procedures across the world fuel the incidence of SSIs, which drives the growth of the preoperative infection prevention & wound cleansing devices market.

SSIs place a significant clinical and economic burden on patients and the healthcare system, primarily due to increased morbidity, mortality, and hospital expenses. Prevention of SSIs requires surveillance activities leading to effective mitigation strategies. According to the CDC guidelines, SSI is classified into superficial incisional SSI, internal deep incisional SSI, and organ SSI. Factors such as contamination level and surgical techniques have been identified as strong predictors of SSI occurrence. According to the Medical Journal of Indonesia, recent studies have shown that host factors such as age, gender, nutritional status, lifestyle, obesity, comorbidities, and preoperative assessment played a critical role in developing SSI complications. According to the Agency of Healthcare Research and Quality, SSIs occur in ~2 to 4% of all the patients that undergo inpatient surgical procedures. SSIs are the leading cause of readmission to the hospital after surgery, and about 3% of the patients that acquire SSIs die. Owing to the rising number of SSIs cases, hospitals and healthcare centers are opting for preoperative infection prevention procedures to avoid the possibility of SSIs. Therefore, the need for preoperative infection prevention is growing.

North America held the largest share of the preoperative infection prevention & wound cleansing device market in 2021 The region is seeing an increase in research and development in the field of imaging technology, which is driving the overall market during the forecast period.

The preoperative infection prevention & wound cleansing device market in the US was valued at US$ 645.02 million in 2021 and is projected to reach US$ 1,014.21 million by 2028; it is expected to grow at a CAGR of 6.7% during the forecast period. The US represents the most considerable supply market for preoperative infection prevention and wound cleansing devices, which bolsters the market growth in the country.

During COVID-19 outbreak, hospital admissions were on the rise. Regarding the total annual cost spent by healthcare facilities on these infections, SSIs are the largest contributor in the US. The most common types of hospital acquired infections (HAIs) cost around US$ 9.8 billion annually in the US, with SSIs contributing the largest share of 33.7% (US$ 3.3 billion). The reasons behind the high cost of SSIs are prolonged hospitalization of patients and associated diagnostic tests & treatments, which leads to an increase in additional cost burden. Hence, it is necessary to control infections during surgical procedures to reduce this burden, which is expected to drive the market for SSI control products in the coming years.

Cardinal Health; 3M; Bactiguard; BD; Getinge AB; bioMerieux SA; Medline Industries, Inc.; Dynarex Corporation; Steris plc; and Careon Healthcare Solutions are among the leading companies operating in the global preoperative infection prevention & wound cleansing device market.

The preoperative infection prevention & wound cleansing device market is segmented on the basis of product, surgery, application, and geography. Based on product, the market is bifurcated into preoperative infection prevention devices and preoperative wound cleansing devices. Based on surgery, the market is segmented into cataract surgery, cesarean surgery, gastric bypass, appendectomy, colectomy and colostomy, esophagectomy, biopsy, cholecystectomy, mastectomy, cosmetic surgery, and others. In terms of application, the preoperative infection prevention & wound cleansing device market is segmented into preoperative hair removal, preoperative skin preparation, intraoperative wound irrigation solution, and others.

In terms of geography, the preoperative infection prevention & wound cleansing device market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com